Insulet (PODD) Gross Profit (2010 - 2026)

Insulet has reported Gross Profit for 17 years, with the latest figure at $529.1 million in Q1 2026.

• For the quarter ending Q1 2026, Gross Profit rose 29.36% year-over-year to $529.1 million; the trailing twelve-month figure through Mar 2026 stood at $2.1 billion (up 33.08% YoY), and the FY2025 full-year result was $1.9 billion, up 34.18% from the prior year.
• Gross Profit for Q1 2026 stood at $529.1 million, down from $568.6 million in the prior quarter.
• The five-year high for Gross Profit was $568.6 million in Q4 2025, with the low at $188.3 million in Q3 2022.
• Historically, Gross Profit has averaged $345.9 million across 5 years, with a median of $330.9 million in 2024.
• Annual changes were most pronounced in 2022 — Gross Profit slipped 0.21% — and 2023, when it soared 66.22%.
• Insulet's Gross Profit stood at $217.3 million in 2022, then soared by 66.22% to $361.2 million in 2023, then rose by 19.3% to $430.9 million in 2024, then surged by 31.96% to $568.6 million in 2025, then dropped by 6.95% to $529.1 million in 2026.
• The last three Gross Profit figures came in at $529.1 million (Q1 2026), $568.6 million (Q4 2025), and $510.1 million (Q3 2025), per Business Quant data.